DUBLIN–(BUSINESS WIRE)–The “International Single-cell Evaluation Market by Cell Sort (Human, Animal, Microbial), Product (Consumables, Instrument), Method (Stream Cytometry, NGS, PCR, Microscopy, MS), Utility (Analysis, Medical), Finish Consumer (Pharma, Biotech, Hospitals) – Forecast to 2026” report has been added to ResearchAndMarkets.com’s providing.
The worldwide single-cell evaluation market is projected to succeed in USD 6.3 billion by 2026 from USD 3.1 billion in 2021, at a CAGR of 15.1% in the course of the forecast interval.
Development within the single-cell evaluation market can primarily be attributed to elements akin to technological developments in single-cell evaluation merchandise, rising prevalence of most cancers, growing R&D within the pharmaceutical & biotechnology industries for complicated illnesses, development in stem cell analysis, and rising give attention to personalised medication. However, the excessive price of single-cell evaluation devices is anticipated to hinder market development to a sure extent.
The consumables section accounted for the very best development price within the single-cell evaluation market, by product, in the course of the forecast interval
Consumables accounted for the biggest share of 67.4% of the single-cell evaluation market in 2020. The massive share of this section can primarily be attributed to the frequent buy of those merchandise in comparison with devices, that are thought-about a one-time funding. The huge functions of consumables in analysis and genetic exploration, exosome evaluation, and isolation of RNA and DNA are additionally anticipated to drive market development.
The human cells section accounted for the biggest share
The one-cell evaluation market is segmented into human cells, animal cells, and microbial cells. The human cells section accounted for the biggest share of 51.6% of the single-cell evaluation market in 2020. The massive share of this section may be attributed to the excessive utilization of human cells in analysis laboratories and educational institutes.
Asia Pacific: The fastest-growing area within the single-cell evaluation market
The market within the Asia Pacific is anticipated to develop on the highest CAGR of 17.4% in the course of the forecast interval. This may be attributed to the fast-growing pharmaceutical business on this area, rising geriatric inhabitants, rising prevalence of most cancers, and growing authorities initiatives.
The distinguished gamers within the single-cell evaluation market are Becton, Dickinson and Firm (US), Danaher Company (US), Merck Millipore (US), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (US), Promega Company (US), Illumina, Inc. (US), Fluidigm Company (US), 10x Genomics (US), and Corning Integrated (US).
- Technological Developments In Single-Cell Evaluation Merchandise To Assist Market Development
- Consumables Accounted for the Largest Share of the North American Single-Cell Evaluation Market In 2020
- Consumables Will Proceed To Dominate the Single-Cell Evaluation Market In 2026
- Tutorial & Analysis Laboratories Accounted for the Largest Market Share In 2020
- Asia Pacific To Register the Highest Development Within the Single-Cell Evaluation Market From 2021 To 2026
- Technological developments in single-cell evaluation merchandise
- Rising prevalence of most cancers
- Growing R&D within the pharmaceutical & biotechnology industries for complicated illnesses
- Development in stem cell analysis
- Rising give attention to personalised medication
- Excessive price of single-cell evaluation merchandise
- Excessive development potential of single-cell sequencing
- Integration of microfluidics in single-cell evaluation
- Rising Asian markets
- Becton, Dickinson and Firm
- Danaher Company
- Merck KgaA
- Thermo Fisher Scientific, Inc.
- Qiagen N.V.
- 10X Genomics
- Promega Company
- Bio-Rad Laboratories
- Fluidigm Company
- AGilent Applied sciences, Inc.
- Corning Integrated
- Takara Bio Inc.
- Biomerieux SA
- Tecan Group Ltd.
- Sartorius AG
- Luminex Company
- Oxford Nanopore Applied sciences
- Cytek Biosciences
- Fluxion Biosciences
- Menarini Silicon Biosystems
- Apogee Stream Techniques Ltd.
- Nanocellect Biomedical
- On-Chip Biotechnologies Co., Ltd.
- Rarecyte, Inc.
For extra details about this report go to https://www.researchandmarkets.com/r/tw03qc